Product Description
a new enema (TF037) against Fleet enema in distal bowel cleansing. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01715272)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Norgine
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 1: Other
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| NER1008-01/2012 (DBC) | P1 |
Completed |
Other |
2012-12-01 |